| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 6.421 | 25.871 | 49.315 | 79.513 | 82.716 | 74.179 | 672 | 0 | 0 | 0 |
| Total Income - EUR | 6.421 | 25.871 | 49.391 | 79.513 | 82.718 | 74.179 | 674 | 0 | 0 | 0 |
| Total Expenses - EUR | 4.963 | 13.770 | 28.101 | 44.736 | 49.579 | 62.909 | 3.246 | 5.203 | 364 | 4.815 |
| Gross Profit/Loss - EUR | 1.458 | 12.101 | 21.290 | 34.776 | 33.139 | 11.270 | -2.571 | -5.203 | -364 | -4.815 |
| Net Profit/Loss - EUR | 1.266 | 11.292 | 20.365 | 33.984 | 32.312 | 10.599 | -2.578 | -5.203 | -364 | -4.815 |
| Employees | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Biovitaprotex S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 23 | 46 | 0 | 38 | 15 | 0 | 14.144 | 12.634 |
| Current Assets | 5.090 | 15.342 | 32.931 | 60.810 | 67.456 | 77.133 | 67.029 | 62.049 | 74.391 | 31.427 |
| Inventories | 3.123 | 7.546 | 12.830 | 11.049 | 12.585 | 323 | 0 | 0 | 25.395 | 25.209 |
| Receivables | 328 | 2.957 | 2.978 | 4.979 | 5.576 | 5.280 | 7.662 | 4.077 | 41.034 | 3.441 |
| Cash | 1.639 | 4.839 | 17.122 | 44.782 | 49.296 | 71.531 | 59.367 | 57.972 | 7.962 | 2.777 |
| Shareholders Funds | 2.281 | 12.448 | 28.225 | 56.813 | 61.893 | 70.837 | 66.688 | 61.692 | 50.668 | 43.897 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.808 | 2.894 | 4.728 | 4.043 | 5.563 | 6.334 | 356 | 357 | 37.868 | 163 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Biovitaprotex S.r.l.